Mortality prediction models after radical cystectomy for bladder tumour: A systematic review and critical appraisal
Open Access
- 13 June 2022
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 52 (10), e13822
- https://doi.org/10.1111/eci.13822
Abstract
Introduction To identify risk-predictive models for bladder-specific cancer mortality in patients undergoing radical cystectomy and assess their clinical utility and risk of bias. Methods Systematic review (CRD42021224626:PROSPERO) in Medline and EMBASE (from their creation until 31/10/2021) was screened to include articles focused on the development and internal validation of a predictive model of specific cancer mortality in patients undergoing radical cystectomy. CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS) and Prediction model Risk Of Bias ASsessment Tool (PROBAST) were applied. Results Nineteen observational studies were included. The main predictors were sociodemographic variables, such as age (18 studies, 94.7%) and sex (17, 89.5% studies), tumour characteristics (TNM stage (18 studies, 94.7%), histological subtype/grade (15 studies, 78.9%), lymphovascular invasion (10 studies, 52.6%) and treatment with chemotherapy (13 studies, 68.4%). C-index values were presented in 14 studies. The overall risk of bias assessed using PROBAST led to 100% of studies being classified as high risk (the analysis domain was rated to be at high risk of bias in all the studies), and 52.6% showed low applicability. Only 5 studies (26.3%) included an external validation and 2 (10.5%) included a prospective study design. Conclusions Using clinical predictors to assess the risk of bladder-specific cancer mortality is a feasibility alternative. However, the studies showed a high risk of bias and their applicability is uncertain. Studies should improve the conducting and reporting, and subsequent external validation studies should be developed.Keywords
This publication has 50 references indexed in Scilit:
- Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4aUrologic Oncology, 2013
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2012
- Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical CystectomyUrology, 2012
- Systematic reviews in nutrition: standardized methodologyBritish Journal of Nutrition, 2012
- A new prognostic model for cancer‐specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factorsBJU International, 2012
- Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C‐reactive protein and standard pathological risk factors: the TNR‐C scoreBJU International, 2011
- Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladderJournal of Clinical Pathology, 2010
- Are nomograms needed in the management of bladder cancer?Urologic Oncology, 2010
- Contemporary Open Radical Cystectomy: Analysis of Perioperative OutcomesJournal of Urology, 2008
- Nomograms Provide Improved Accuracy for Predicting Survival after Radical CystectomyClinical Cancer Research, 2006